Pivagabine

Chemical compound From Wikipedia, the free encyclopedia

Pivagabine (INN; brand name Tonerg), also known as N-pivaloyl-γ-aminobutyric acid or N-pivaloyl-GABA, is an antidepressant and anxiolytic drug which was introduced in Italy in 1997 for the treatment of depressive and maladaptive syndromes. But it was discontinued in Italy (according to Martindale). Originally believed to function as a prodrug to GABA,[1] pivagabine is now believed to act somehow via modulation of corticotropin-releasing factor (CRF).[2][3][4][5][6]

Quick facts Names, Identifiers ...
Pivagabine
Seletal formula of pivagabine with some implicit hydrogens shown
Seletal formula of pivagabine with some implicit hydrogens shown
Names
Preferred IUPAC name
4-(2,2-Dimethylpropanamido)butanoic acid
Identifiers
3D model (JSmol)
ChemSpider
ECHA InfoCard 100.067.287 Edit this at Wikidata
EC Number
  • 274-038-3
KEGG
MeSH N-trimethylacetyl-4-aminobutyric+acid
UNII
  • InChI=1S/C9H17NO3/c1-9(2,3)8(13)10-6-4-5-7(11)12/h4-6H2,1-3H3,(H,10,13)(H,11,12) checkY
    Key: SRPNQDXRVRCTNK-UHFFFAOYSA-N checkY
  • CC(C)(C)C(=O)NCCCC(O)=O
Properties
C9H17NO3
Molar mass 187.239 g·mol−1
Pharmacology
N06AX15 (WHO)
Oral
Pharmacokinetics:
6.4 hours
Legal status
  • In general: ℞ (Prescription only)
Related compounds
Related alkanoic acids
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Close

See also

References

Related Articles

Wikiwand AI